Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema

Lymphology

Volumn 43, Issue 4, 2010, Pages 178-187

  Hayes, Sandra C ^a   Rye, S ^a   Battistutta, D ^a   Newman, B ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Arm function; Breast cancer; Lymphedema; Lymphedema risk; Upper body symptoms

Indexed keywords

ADULT; ARM MOVEMENT; ARTICLE; AUSTRALIA; BREAST CANCER; FEMALE; HUMAN; LONGITUDINAL STUDY; LYMPHEDEMA; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGED; ARM; BREAST NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; MIDDLE AGED; PREVALENCE;

EID: 79952304331     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gill, G: The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS), and NHMRC Clinical Trials Centre. Sentinel- lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomised controlled surgical trial. Ann. Surg. Oncol. 16 (2009), 266-275.
2. Rietman, JS, PU Kijkstra, JHB Geertzen, et al: Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann. Surg. Oncol. 11 (2004), 1018-1024.
3. Schrenk, P, R Rieger, A Shamiyeh, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 (2000), 608-614. (Pubitemid 30056936)
4. Gosselink, R, L Rouffaer, P Vanhelden, et al: Recovery of upper limb function after axillary dissection. J. Surg. Oncol. 83 (2003), 204-211.
5. Haid, A, R Koberle-Wuhrer, M Knauer, et al: Morbidity of breast cancer patients following complete axillar dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res. Treat. 73 (2002), 31-36.
6. Leidenius, M, E Leppanen, L Krogerus, et al: Motion restriction and axillary web syndrom after sentinel node biopsy and axillary clearance in breast cancer. Am. J. Surg. 185 (2003), 127-130.
7. Peintinger, F, R Reitsamer, H Stranzi, et al: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br. J. Cancer 89 (2003), 648-652. (Pubitemid 37076167)
8. Rietman, JS, PU Kijkstra, HJ Hoekstra, et al: Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: A systematic review. Eur. J. Surg. Oncol. 29 (2003), 229-238.
9. Rietman, JS, PU Dijkstra, R Debreczeni, et al: Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil. Rehabil. 26 (2004), 78-84.
10. Ververs, JM, RM Roumen, AJ Vingerhoets, et al: Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur. J. Cancer 37 (2001), 991-999. (Pubitemid 32397684)
11. Thomas-MacLean, RL, T Hack, W Kwan, et al: Arm morbidity and disability after breast cancer: New directions for care. Oncol. Nurs. Forum 35 (2008), 65-71.
12. Hayes, SC, M Janda, B Cornish, et al: Lymphoedema following breast cancer: incidence, risk factors and effect on upper body function. J. Clin. Oncol. 26 (2008), 3536-3542.
13. Brady, M, D Cella, F Mo, et al: Reliability and validity of the Functional Assessment of Cancer Therapy - Breast (FACT-B) quality of life instrument. J. Clin. Oncol. 15 (1997), 974-986.
14. Coster, S, K Poole, LJ Fallowfield: The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res. Treat. 68 (2001), 273-282.
15. nd Ed, 2002, Toronto: Institute for Work and Health.
16. Hayes, S, D Battistutta, B Newman: Objective and subjective upper-body function six months following diagnosis of breast cancer. Breast Cancer Res. Treat. 94 (2005), 1-10.
17. Cornish, B, M Chapman, C Hirst, et al: Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34 (2001), 2-11. (Pubitemid 32549826)
18. Cornish, B, L Ward, B Thomas, et al: Quantification of lymphoedema using multi-frequency bioimpedance. Appl. Radiat. Isotopes 49 (1998), 651-652.
19. Karki, A, R Simonen, E Malkia, et al: Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J. Rehabil. Med. 37 (2005), 180-188.
20. Sprangers, MA, M Groenvold, JI Arraras, et al: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J. Clin. Oncol. 14 (1996), 2756-2768.
21. Hayes, SC, Review of Research Evidence on Secondary Lymphoedema: Incidence, prevention, risk factors and treatment. 2008, National Breast and Ovarian Cancer Centre, p. http://www.nbocc.org.au/bestpractice/resources/ SLER247-reviewofresearchevid.pdf.
22. Hayes, SC, M Janda, B Cornish, et al: Lymphoedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence and identifiable risk factors. Lymphology 41 (2008), 18-28. (Pubitemid 351747151)